z-logo
Premium
SHORT DIAGNOSIS‐TO‐TREATMENT INTERVAL IS ASSOCIATED WITH HIGH RISK AND POOR OUTCOMES IN DIFFUSE LARGE B‐CELL LYMPHOMA
Author(s) -
Casan J.,
Ansell E.,
Davies A.,
Gilbertson M.,
Opat S.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.84_2631
Subject(s) - medicine , clinical trial , diffuse large b cell lymphoma , confidence interval , proportional hazards model , hazard ratio , oncology , lymphoma

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom